Diagnostyka S.A. (DIA.WA) has a MoatMap StockRank of 76/100 based on Quality (67/100), Value (44/100), and Momentum (49/100) factor scores. The current signal is BUY. Diagnostyka is a Polish medical diagnostics provider. While healthcare is defensive, it lacks a clear global macro catalyst and does not fit into our high-conviction themes like the CDMO pricing cycle.
Diagnostyka S.A. provides laboratory diagnostics services, operating a vast network of medical laboratories and collection points in Poland. The company is the undisputed market leader in Polish medical diagnostics, offering thousands of different test types to public and private healthcare providers. It is a highly consolidated, scale-driven healthcare player with advanced automated laboratory infrastructure.
| Price | $48.22 |
| Market Cap | $1.7B |
| P/E (TTM) | 22.21 |
| P/E (Forward) | 15.99 |
| Price/Book | 10.98 |
| Return on Equity | 53.4% |
| Return on Invested Capital | 24.7% |
| Debt/Equity | 197.49 |
| Gross Margin | 79.2% |
| Operating Margin | 10.6% |
| Revenue Growth | 19.3% |
| Dividend Yield | 2.5% |
| Free Cash Flow | $18M |
Diagnostyka S.A. operates in the Diagnostics & Research industry, part of the Healthcare sector (Poland).